<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02587286</url>
  </required_header>
  <id_info>
    <org_study_id>Gather mHealth 1</org_study_id>
    <nct_id>NCT02587286</nct_id>
  </id_info>
  <brief_title>Gather mHealth India RCT for Behavior and Health Outcomes</brief_title>
  <official_title>Investigation of the Gather mHealth Platform on Diabetics' Behavior and Health Outcomes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gather Health India</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DHL Innovation Center, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Diabetes Action Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>M.V. Hospital for Diabetes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gather Health India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to explore the impact of the Gather Health diabetes management
      platform diabetics' health behaviors and health outcomes and how providers and diabetics
      interact with the Gather Health platform.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall aim of the study is to estimate the impact of the Gather Health diabetes
      management platform on HbA1c, glycemic control, patient behavior, and physical and
      psychosocial measures. Additionally, this study will investigate patient and provider
      satisfaction with the platform.

      Primary Objective:

      Estimate the impact of the Gather Health diabetes management platform on HbA1c among
      diabetics in 3 cities in India.

      Secondary Objective:

        1. Estimate the impact of the Gather Health diabetes management platform on medication
           adherence, blood glucose (BG) control, body mass index (BMI), blood pressure (BP), and
           other behavior and health measures among diabetics in 3 cities in India.

        2. Estimate patient and provider's satisfaction with the platform and the perceived
           usability and time spent on the platform

        3. Generate ideas for future changes to the platform to make it more effective and
           user-friendly
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>BMI</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Blood pressure</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Waist Circumference</measure>
    <time_frame>6 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fasting Blood Glucose</measure>
    <time_frame>6 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Lipids</measure>
    <time_frame>6 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes Self-care activities</measure>
    <time_frame>6 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>6 Months</time_frame>
    <description>Stanford scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes Knowledge</measure>
    <time_frame>6 Months</time_frame>
    <description>Adaptation of RAND measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>6 Months</time_frame>
    <description>Visual Analog Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood Glucose Testing Adherence</measure>
    <time_frame>6 Months</time_frame>
    <description>Visual Analog Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment Satisfaction</measure>
    <time_frame>6 Months</time_frame>
    <description>Adapted RAND measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes Distress</measure>
    <time_frame>6 Months</time_frame>
    <description>PAID-5</description>
  </other_outcome>
  <other_outcome>
    <measure>mHealth intervention satisfaction</measure>
    <time_frame>6 Months</time_frame>
    <description>Investigator generated</description>
  </other_outcome>
  <other_outcome>
    <measure>BMI</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Blood pressure</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Waist Circumference</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fasting Blood Glucose</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Lipids</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes Self-care activities</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Self-efficacy</measure>
    <time_frame>3 months</time_frame>
    <description>Stanford Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes knowledge</measure>
    <time_frame>3 months</time_frame>
    <description>Adapted RAND measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Med Adherence</measure>
    <time_frame>3 months</time_frame>
    <description>Visual Analog Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>BG Testing Adherence</measure>
    <time_frame>3 months</time_frame>
    <description>Visual Analog Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment Satisfaction</measure>
    <time_frame>3 months</time_frame>
    <description>Adapted RAND measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes Distress</measure>
    <time_frame>3 months</time_frame>
    <description>PAID-5</description>
  </other_outcome>
  <other_outcome>
    <measure>mHealth intervention satisfaction</measure>
    <time_frame>3 months</time_frame>
    <description>Investigator generated</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Gather app</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the Gather mHealth diabetes management system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group participants will be recruited from the same clinics and will also fit all study inclusion and exclusion criteria. Participants will be recommended to test their BG as per usual care in India. Providers will not contact control group participants between regular visits, though they will respond to queries directed at them in typical fashion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gather app</intervention_name>
    <description>Participants in the intervention group will receive the Gather Health software free for the duration of the study. Their medication and BG testing goals will be entered into the system and they will receive automated reminders. Their data will be regularly reviewed by study staff and feedback provided.</description>
    <arm_group_label>Gather app</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus, diagnosis for &gt; 6 months.

          -  Age 18-65, participants of either gender- males or females.

          -  HbA1c between 7.5% and 12.5% within last 6 months (inclusive).

          -  On stable diabetes therapy for &gt;3 months prior to enrollment.

          -  Own an Android Smartphone.

          -  Participant willing to sign and date written Informed Consent Form to participate in
             the study.

          -  Willing to comply with the study schedule and procedures including randomization.

        Exclusion Criteria:

          -  Previously used Gather Health

          -  Currently using an insulin pump or continuous glucose monitor.

          -  Pregnant or planning to become pregnant in the next 12 months.

          -  Severe hearing or visual impairment.

          -  Active substance, alcohol, or drug abuser (sober &lt;1 year).

          -  Any psychiatric illness including psychosis or schizophrenia that will impair the
             patient's ability to complete the study or follow study protocol.

          -  Recent major surgery or planning to have major surgery

          -  Significant renal, hepatic, or other disease that may impair patient's ability to
             complete the study or follow study protocol

          -  Using glucocorticoids

          -  Patients who have received or are planning to receive an organ transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjiv Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diabetes Action Centre</affiliation>
  </overall_official>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2015</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2015</study_first_posted>
  <last_update_submitted>January 20, 2016</last_update_submitted>
  <last_update_submitted_qc>January 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mHealth</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Glucose control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>posted to clinicaltrials.gov</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

